Which has grown faster, CRL or MEDP?

Over the past five years, MEDP grew revenue faster — CRL at a 5.77% CAGR versus MEDP at 22.91%.

Is CRL or MEDP more profitable?

MEDP runs the higher net margin — CRL at -4.59% versus MEDP at 17.19%.

Which has been the better investment, CRL or MEDP?

Over the past 5-year, MEDP delivered the higher annualized total return — CRL at 8.32% versus MEDP at 20.25%. Past performance doesn't predict future results.

Charles River Laboratories International, Inc. (CRL) vs Medpace Holdings, Inc. (MEDP)

MEDP leads on 10 of 14 compared metrics.

A side-by-side comparison of Charles River Laboratories International, Inc. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CRL

Charles River Laboratories International, Inc.

$8.90B

$184.79Healthcare

MEDP

Medpace Holdings, Inc.

$13.05B

$457.09Healthcare

Total return — CRL vs MEDP

growth of $100 · last 10y

CRL +121.9%MEDP +1561.0%MEDP compounded faster

Log scale — wide-divergence pair

CRL MEDP

CRL vs MEDP: by the numbers

•MEDP is the larger company ($13.05B vs $8.90B market cap).
•MEDP is profitable (17.19% net margin) while CRL runs a net loss (-4.59%).
•MEDP grew revenue faster over the past five years (22.91% vs 5.77% CAGR).

Which is better, CRL or MEDP?

Metric tally: CRL 4 · MEDP 10

It depends on what you're optimizing for:

GrowthMEDP(faster 5Y revenue CAGR)

QualityMEDP(higher ROIC)

Metrics side by side

Valuation

Metric	CRL	MEDP
P/E ratio	—	28.71
Forward P/E	14.99●	24.88
P/S ratio	2.25●	4.94
P/B ratio	3.08●	22.13
PEG ratio	—	1.82
EV / EBITDA	40.99	21.18●
FCF yield	4.33%	5.57%●

Profitability

Metric	CRL	MEDP
Gross margin	31.86%●	29.07%
Operating margin	11.77%	21.02%●
Net margin	-4.59%	17.19%●
ROE	-6.28%	76.95%●
ROIC	8.36%	67.94%●

Growth (annualized)

Metric	CRL	MEDP
Revenue CAGR (5Y)	5.77%	22.91%●
EPS CAGR (5Y)	-40.99%	30.90%●
FCF CAGR (5Y)	-3.98%	25.76%●
Total return CAGR (5Y)	-12.14%	20.25%●

Frequently asked

Which is better, CRL or MEDP?: It depends on your goal. growth: MEDP (faster 5Y revenue CAGR); quality: MEDP (higher ROIC). Across all compared metrics, MEDP leads 10 to 4.
Which has grown faster, CRL or MEDP?: Over the past five years, MEDP grew revenue faster — CRL at a 5.77% CAGR versus MEDP at 22.91%.
Is CRL or MEDP more profitable?: MEDP runs the higher net margin — CRL at -4.59% versus MEDP at 17.19%.
Which has been the better investment, CRL or MEDP?: Over the past 5-year, MEDP delivered the higher annualized total return — CRL at 8.32% versus MEDP at 20.25%. Past performance doesn't predict future results.

Go deeper

Full CRL analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Charles River Laboratories International P/E ratio Medpace P/E ratio Charles River Laboratories International dividend yield Medpace dividend yield Charles River Laboratories International ROE Medpace ROE Charles River Laboratories International operating margin Medpace operating margin Charles River Laboratories International revenue growth Medpace revenue growth Charles River Laboratories International free cash flow Medpace free cash flow

Charles River Laboratories International & Medpace appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.